Transgenomic Inc (TBIO1)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
LABORATORY ANALYTICAL INSTRUMENTS
CEO:
Paul Kinnon
Employees:
42
12325 EMMET ST, OMAHA, NE 68164
4027385480

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Transgenomic, Inc. is a global biotechnology company, which provides personalized medicine in the detection and treatment of cancer and inherited diseases through its proprietary molecular technologies and world-class clinical and research services. It operates through the following reportable segments: Laboratory Services and Genetic Assays and Platforms. The Laboratory Services segment is a combination of clinical laboratories and pharmacogenomic services business segments. The Clinical Laboratories segment specializes in genetic testing for cardiology, neurology, mitochondrial disorders and oncology. The Laboratory Services segment also provides pharmacogenomics research services supporting Phase II and Phase III clinical trials conducted by pharmaceutical companies and it employs a variety of genomic testing service technologies, including ICE COLD-PCR technology.The Genetic Assay and Platforms segment includes WAVE System product, which has broad applicability to genetic variation detection in both molecular genetic research and molecular diagnostics. This segment also manufactures and sells consumable products that can be used on multiple, independent platforms. These products include SURVEYOR Nuclease and a range of chromatography columns. Transgenomic was founded on March 6, 1997 and is headquartered in Omaha, NE.

Data derived from most recent annual or quarterly report
Market Cap 17.722 Million Shares Outstanding26.45 Million Avg 30-day Volume 1.488 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-0.08
Price to Revenue3.7671 Debt to Equity0.0076 EBITDA-7.844 Million
Price to Book Value1.3571 Operating Margin-108.6337 Enterprise Value21.893 Million
Current Ratio3.199 EPS Growth0.529 Quick Ratio2.935
1 Yr BETA 0.1518 52-week High/Low 0.0 / Profit Margin-96.2482
Operating Cash Flow Growth11.5281 Altman Z-Score-0.6073 Free Cash Flow to Firm -7.335 Million
View SEC Filings from TBIO1 instead.

View recent insider trading info

Funds Holding TBIO1 (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding TBIO1 BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

LAPORTE KATHLEEN

  • Director
25,000 2021-08-03 1

SANDBERG RICHARD A

  • Director
25,000 2021-08-03 1

ANDREWS RONALD ASBURY

  • Director
25,000 2021-08-03 1

DANIELI ILAN CHIEF FINANCIAL OFFICER

  • Officer
  • Director
360,000 2021-08-03 1

FISHER DOUGLAS

  • Director
25,000 2021-08-03 1

IBERGER CARL CHIEF FINANCIAL OFFICER

  • Officer
250,000 2021-08-03 1

COSSMAN JEFFREY

  • Director
25,000 2021-08-03 1

COHEN DAVID SETH

  • Director
25,000 2021-08-03 3

RIMER MARK

  • Director
0 2020-07-02 0

RICCITELLI SAMUEL D

  • Director
0 2019-03-18 0

RENAUD RONALD C JR CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
  • PRESIDENT
0 2019-03-08 0

BARBIER ANN CHIEF MEDICAL OFFICER

  • Officer
0 2019-03-08 0

SCHROER JOHN R. CHIEF FINANCIAL OFFICER

  • Officer
  • TREASURER
0 2019-03-08 0

BURGESS PAUL D. CHIEF LEGAL OFFICER

  • Officer
  • SECRETARY
0 2019-03-08 0

HEARTLEIN MICHAEL CHIEF SCIENTIFIC OFFICER

  • Officer
  • CHIEF TECHNICAL OFFICER
0 2019-03-08 0

CLOGHESSY PAULA CHIEF HUMAN RESOURCES OFFICER

  • Officer
0 2019-03-08 0

FENTON BRIAN CHIEF BUSINESS OFFICER

  • Officer
0 2019-03-08 0

MEYER ROBERT J.

  • Director
0 2019-01-02 0

KIRK RANDAL J

  • 10% Owner
No longer subject to file 2018-08-28 0

SHIRE HUMAN GENETIC THERAPIES, INC.

SHIRE PLC

  • 10% Owner
7,078,945 2018-07-02 0

FORMELA JEAN FRANCOIS

  • Director
3,922,010 2018-07-02 0

OMEGA FUND IV, L.P.

OMEGA FUND IV GP, L.P.

OMEGA FUND IV G.P. MANAGER, LTD.

OMEGA FUND V, L.P.

OMEGA FUND V GP, L.P.

OMEGA FUND V GP MANAGER, LTD.

STAMPACCHIA OTELLO

LIM RICHARD J.

PASTER ANNE-MARI

NESSI CLAUDIO

  • 10% Owner
No longer subject to file 2018-07-02 0

ATLAS VENTURE FUND VIII, L.P.

ATLAS VENTURE ASSOCIATES VIII, L.P.

ATLAS VENTURE ASSOCIATES VIII, INC.

  • 10% Owner
No longer subject to file 2018-07-02 0

GLAXOSMITHKLINE PLC

  • 10% Owner
0 2018-06-27 0

LYNCH DANIEL

  • Director
321,825 2018-06-27 0

BECKMAN DANIELLA

  • Director
0 2018-06-27 0

HUGHES OWEN

  • Director
29,860 2018-06-27 0

GALLAGHER BRIAN M. JR.

  • Director
0 2018-06-27 0

MRL VENTURES FUND LLC

  • 10% Owner
0 2018-06-27 0

LUTHER MICHAEL A

  • Director
0 2018-02-16 0

PATZIG ROBERT

  • Director
0 2017-09-26 0

KOPPLER DOIT II

  • Director
0 2016-12-13 0

THOMAE MYA

  • Director
0 2016-12-13 0

THOMPSON JOHN D

  • Director
0 2015-04-01 0

RICHARDS LEON CHIEF ACCOUNTING OFFICER

  • Officer
0 2015-04-01 0

KINNON PAUL CEO, PRESIDENT AND INTERIM CFO

  • Officer
  • Director
0 2015-04-01 0

DOUGLAS KEVIN

DOUGLAS MICHELLE

DOUGLAS FAMILY TRUST

JAMES & JEAN DOUGLAS IRREVOCABLE DESCENDANTS TRUST

DOUGLAS JAMES E III

  • 10% Owner
  • 13(D)(3) GROUP13(D)(3) GROUP13(D)(3) GROUP13(D)(3) GROUP13(D)(3) GROUP
816,664 2014-05-22 0

KOPP LEROY C

  • 10% Owner
No longer subject to file 2014-05-22 0

COLONNESE MARK P CHIEF FINANCIAL OFFICER

  • Officer
0 2013-09-30 0

KIRK RANDAL J

THIRD SECURITY SENIOR STAFF 2008 LLC

THIRD SECURITY STAFF 2010 LLC

THIRD SECURITY INCENTIVE 2010 LLC

  • 10% Owner
245,903 2011-11-08 0

TUTTLE CRAIG JAMES PRESIDENT AND CEO

  • Officer
0 2011-05-18 0

FREVERT BRETT L CHIEF FINANCIAL OFFICER

  • Officer
0 2011-05-18 0

RICHARDS CHAD M CHIEF COMMERCIAL OFFICER

  • Officer
43,800 2011-05-18 0

SCHUH ANTONIUS

  • Director
0 2011-03-02 0

MARKIN RODNEY S

  • Director
0 2011-03-02 0

SLOMA GREGORY T

  • Director
0 2010-06-07 0

SKLAR JEFFREY L

  • Director
0 2010-06-07 0

MCNULTY MICHAEL B

  • Director
0 2010-06-07 0

DUMAN GREGORY J

  • Director
400 2008-12-15 0

KALDJIAN ERIC P CHIEF SCIENTIFIC OFFICER

  • Officer
0 2008-12-09 0

WITNEY FRANK R

  • Director
0 2008-05-21 0

PAULUZZI DAVID P

  • Director
0 2008-03-10 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments